Canaccord’s Susan Anderson Trims Perrigo (PRGO) Target but Notes Share Gains in Core Business

Core Insights - Perrigo Company plc (NYSE:PRGO) is recognized as one of the 13 Extreme Dividend Stocks with significant upside potential [1] - Canaccord analyst Susan Anderson has reduced the price target for Perrigo from $20 to $17 while maintaining a Buy rating, highlighting share gains in both private label and core branded businesses despite challenges in the infant nutrition segment [2] - The company reported improved operating income and earnings per share (EPS) compared to the previous year, with a focus on simplifying operations through its Three-S Plan [3] Financial Performance - In Q4 2025, Perrigo achieved earnings per share in line with revised guidance, indicating a recovery in performance [3] - Market share gains accelerated throughout the year, reversing a trend of declines, with over $100 million captured in new distribution wins [4] - The infant nutrition segment showed signs of stabilization, and supply conditions in the infant formula category improved [4] Strategic Developments - Perrigo plans to divest its Dermacosmetics business, with the transaction expected to close in Q2 2026 [4] - The company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI), focusing on over-the-counter health and wellness solutions [5]